In
order to improve bioavailability, stability, control release,
and target delivery of active pharmaceutical ingredients (APIs), as
well as to mask their bitter taste, to increase their efficacy, and
to minimize their side effects, a variety of microencapsulation (including
nanoencapsulation, particle size <100 nm) technologies have been
widely used in the pharmaceutical industry. Commonly used microencapsulation
technologies are emulsion, coacervation, extrusion, spray drying,
freeze-drying, molecular inclusion, microbubbles and microsponge,
fluidized bed coating, supercritical fluid encapsulation, electro
spinning/spray, and polymerization. In this review, APIs are categorized
by their molecular complexity: small APIs (compounds with low molecular
weight, like Aspirin, Ibuprofen, and Cannabidiol), medium APIs (compounds
with medium molecular weight like insulin, peptides, and nucleic acids),
and living microorganisms (such as probiotics, bacteria, and bacteriophages).
This article provides an overview of these microencapsulation technologies
including their processes, matrix, and their recent applications in
microencapsulation of APIs. Furthermore, the advantages and disadvantages
of these common microencapsulation technologies in terms of improving
the efficacy of APIs for pharmaceutical treatments are comprehensively
analyzed. The objective is to summarize the most recent progresses
on microencapsulation of APIs for enhancing their bioavailability,
control release, target delivery, masking their bitter taste and stability,
and thus increasing their efficacy and minimizing their side effects.
At the end, future perspectives on microencapsulation for pharmaceutical
applications are highlighted.